Top Buy
| Security ▲ | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €182.50 | -1.351% |
| Novo Nordisk A/S ADR | 16 | 1 | 0 | 0 | €122.50 | €135.22 | 10.383% |
| Ocular Therapeutix Inc. | 8 | 5 | 1 | 0 | €5.79 | €12.21 | 111.066% |
| Olympus Corp. | 1 | 0 | 0 | 0 | €14.82 | - | - |
| Omeros Corp. | 2 | 4 | 0 | 0 | €3.77 | - | - |
| Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
| Patterson Companies Inc. | 7 | 0 | 1 | 0 | €23.80 | €32.18 | 35.219% |
| Paul Hartmann AG | 3 | 0 | 0 | 0 | €203.00 | - | - |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €27.90 | €35.99 | 28.980% |
| Personalis Inc | 7 | 0 | 2 | 0 | €1.40 | €3.25 | 132.329% |
| Pfizer Inc. | 30 | 4 | 2 | 0 | €26.53 | €40.66 | 53.287% |
| PharmAust Ltd. | 1 | 0 | 0 | 0 | €0.10 | - | - |
| Phibro Animal Health Corp. A | 4 | 2 | 0 | 1 | €16.60 | €12.06 | -27.325% |
| Poxel S.A. | 1 | 0 | 0 | 0 | €0.62 | €0.70 | 13.269% |
| Precision BioSciences Inc | 7 | 0 | 1 | 0 | €0.35 | €2.90 | 734.167% |
| Pro-Dex Inc. | 15 | 0 | 0 | 0 | €17.20 | - | - |
| ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.76 | €3.03 | 72.409% |
| Prothena Corp. plc | 13 | 0 | 1 | 0 | €20.60 | €80.10 | 288.835% |
| PTC Therapeutics Inc. | 13 | 5 | 1 | 0 | €28.20 | €41.81 | 48.277% |
| Purple Biotech Ltd. ADR | 5 | 0 | 1 | 0 | €0.47 | €9.21 | 1842.405% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Quest Diagnostics Inc. | 4 | 0 | 1 | 0 | €129.35 | €144.44 | 11.670% |
| R1 RCM Inc. | 19 | 0 | 0 | 0 | €11.20 | €17.21 | 53.684% |
| Radnet Inc. | 9 | 3 | 2 | 0 | €54.00 | €54.58 | 1.075% |
| Regeneron Pharmaceuticals Inc. | 35 | 1 | 4 | 0 | €903.60 | €958.32 | 6.055% |